Marchex operates as a conversation-intelligence and AI-enabled marketing-analytics provider, assisting enterprises in sectors like automotive, home services, and healthcare to convert phone calls, texts, and conversations into usable data. The company's outlook centers on a clear repositioning: shifting from standalone analytics sales to bundled AI-powered offerings that deliver not only insights but also automated actions and confirmed outcomes, such as booked appointments and qualified sales conversations.
This bundling approach sits at the core of the strategy. With its largest customers already depending on Marchex for conversational data, management sees room to lift revenue per customer by adding outcome-based products. Certain bundles could roughly double revenue per customer, expanding the addressable market without needing many new clients. That said, competition is intense from larger marketing-technology platforms with greater scale and resources. A concentrated customer base and smaller research-and-development budget represent structural challenges in keeping pace with better-funded AI rivals. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The most significant near-term catalyst is the Archenia acquisition, announced in May 2026 and slated to close in July 2026 pending approval by disinterested stockholders. Archenia focuses on real-time consumer-intent detection and AI-verified, outcome-based customer acquisition. Management expects the combination to create a vertically focused platform covering insights, actions, and outcomes. On a combined basis, guidance points to a revenue run rate of approximately $15 million per quarter, or $60 million annualized, with 15% to 20% growth in 2026 and adjusted EBITDA margins moving toward 10% or higher.
Earnings updates continue to influence sentiment. For the third quarter of 2026, the company expects sequential revenue growth and possible acceleration, with standalone adjusted EBITDA of about $2 million or more, or roughly $2.5 million or more if the Archenia deal closes, implying an annualized run rate of $10 million or more. Management has also highlighted a “Rule of 30 to 40” target, blending annual revenue growth with adjusted EBITDA margins as a medium-term benchmark. From what I see, any new analyst coverage or target change could carry extra weight given the thin coverage. Northland Securities maintains a Buy rating and $4.00 price target on MCHX, with consensus at Moderate Buy and the same average target. A $3 million share-buyback authorization further reflects management’s view that the stock may not fully capture the company’s value.
Marchex’s path ties closely to wider adoption of generative AI and conversational analytics in enterprise marketing. As companies demand clearer returns on customer-acquisition spending, interest in AI-verified outcomes over raw impressions or clicks could support the repositioning. Adoption trends in verticals such as automotive and home services, where phone conversations still drive high-intent purchases, remain especially relevant.
Macro conditions present a mixed picture. The customer base includes discretionary, advertising-heavy sectors that may trim spending if interest rates stay high or consumer demand weakens. Inflation and cost pressures could constrain budgets, while higher financing costs might weigh on small-cap, currently unprofitable firms that investors reward mainly for margin progress. Regulatory developments around AI, data privacy, and call-recording consent also warrant attention, given the reliance on compliant data collection.
Looking ahead, the long-term narrative rests on a few structural elements. If the Archenia integration succeeds, cross-selling and bundling across a larger installed base could unlock what management sees as a $100 million revenue opportunity over time. Cost-structure changes, including platform migration and operational efficiencies, are expected to support margins even before a full revenue pickup.
Margin sustainability will be a key test. Guidance calls for adjusted EBITDA margins of 10% or more in 2026, though maintaining that level depends on operating-expense discipline and turning early paid pilots into recurring, higher-value subscriptions. Technology transitions carry execution risk: shifting customers to the newer Marchex Engage platform has already produced some revenue dilution, and further friction could delay the growth inflection. Competitive pressure from larger AI and marketing-technology vendors, along with revenue concentration in a small number of customers, remains the biggest structural concern. Capital-allocation moves, including the buyback and the Archenia transaction, will indicate how aggressively management aims to strengthen its position. Consensus estimates point to a return to profitability in a few years, and with a single covering analyst at a $4.00 target, sentiment should stay sensitive to execution milestones.
One tool I’ve found useful for monitoring possible directional moves in names like this is Tickeron’s AI Trend Prediction Engine. It supplies AI-powered forecasts to help identify whether a stock may trend bullish, bearish, or sideways over the next week or month, along with historical context and alert features. Pairing these signals with the fundamental catalysts discussed here can provide a more complete forward view.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The RSI Oscillator for MCHX moved out of oversold territory on September 21, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 34 similar instances when the indicator left oversold territory. In 30 of the 34 cases the stock moved higher. This puts the odds of a move higher at 88%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 44 of 63 cases where MCHX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 70%.
The Moving Average Convergence Divergence (MACD) for MCHX just turned positive on September 29, 2026. Looking at past instances where MCHX's MACD turned positive, the stock continued to rise in 39 of 47 cases over the following month. The odds of a continued upward trend are 83%.
Following a +7.03% 3-day Advance, the price is estimated to grow further. Considering data from situations where MCHX advanced for three days, in 164 of 224 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
MCHX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 110 of 153 cases where MCHX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 72%.
The Momentum Indicator moved below the 0 level on October 09, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MCHX as a result. In 80 of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 87%.
The 10-day moving average for MCHX crossed bearishly below the 50-day moving average on September 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 81%.
The 50-day moving average for MCHX moved below the 200-day moving average on October 05, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MCHX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
The Tickeron Valuation Rating of 54 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.016) is normal, around the industry mean (13.387). P/E Ratio (29.140) is within average values for comparable stocks, (43.426). Projected Growth (PEG Ratio) (0.780) is also within normal values, averaging (2.156). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (1.439) is also within normal values, averaging (1.831).
The Tickeron Price Growth Rating for this company is 82 (best 1 - 100 worst), indicating slightly worse than average price growth. MCHX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 84 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 95 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MCHX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 98, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of advertising and marketing services
Industry AdvertisingMarketingServices